Selecting an A1C Point-of-Care Instrument-Reference-Cited by-同舟云学术

Selecting an A1C Point-of-Care Instrument

Published:2015-08-01 Issue:3 Volume:28 Page:201-208
ISSN:1040-9165
Container-title:Diabetes Spectrum
language:en
Short-container-title:

Author:

Whitley Heather P.¹²,Yong Ee Vonn¹,Rasinen Casey¹

Affiliation:

1. Auburn University Harrison School of Pharmacy, Department of Pharmacy Practice, Auburn, AL

2. Baptist Health, Montgomery Family Medicine Residency Program, Montgomery, AL

Abstract

A1C point-of-care (POC) instruments benefit patients with diabetes by facilitating clinician decision making that results in significant glycemic improvements. Three National Glycohemoglobin Standardization Program (NGSP)–certified POC products are available in the United States: the handheld A1CNow (formerly manufactured by Bayer Diabetes Care but now made by Chek Diagnostics) and two bench-top models called the Axis-Shield Afinion Analyzer and the Siemens DCA Vantage. This article compares the three available NGSP-certified POC products in terms of accuracy, precision, ease of use, cost, and additional features. Its goal is to aid health care facilities in conveniently identifying the A1C POC product that best meets their needs. It additionally reviews evidence that supports the continued use of A1C POC instruments in the clinical arena.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/spectrum/article-pdf/28/3/201/504861/201.pdf

Reference35 articles.

1. Futrell K. POCT: POCT supports new demands: changes in healthcare open door for point-of-care testing to improve outcomes. Available from http://laboratory-manager.advanceweb.com/Archives/Article-Archives/POCT-POCT-Supports-New-Demands.aspx. Accessed 26 March 2014

2. Point-of-care testing: millennium technology for critical care;Louie;Lab Med,2000

3. National Institutes of Health. Point-of-care diagnostic testing fact sheet. Available from http://report.nih.gov/nihfactsheets/Pdfs/PointofCareDiagnosticTesting(NIBIB).pdf. Accessed 26 March 2014

4. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients;Cagliero;Diabetes Care,1999

5. AHRQ Technology Assessment Program; U.S. Department of Health and Human Services;Matchar;Point of care testing of hemoglobin A1c

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Disease Risk Factor Control Following Release From Carceral Facilities: A Cross‐Sectional Study;Journal of the American Heart Association;2024-09-09

2. Personal and Social‐Built Environmental Factors of Glucose Variability Among Multiethnic Groups of Adults With Type 2 Diabetes: Research Protocol Using Ecological Momentary Assessment, Continuous Glucose Monitoring, and Actigraphy;Research in Nursing & Health;2024-09-07

3. The Michigan Men’s Diabetes Project Randomized Clinical Control Trial: A Pilot/Feasibility Study of a Peer-Led Diabetes Self-Management and Support Intervention for Black Men With Type 2 Diabetes;American Journal of Men's Health;2024-05

4. Cardiovascular Disease Risk Factor Control Following Release from Carceral Facilities;2024-03-16

5. Associations of childhood BMI traits with blood pressure and glycated haemoglobin in 6–9‐year‐old Samoan children;Pediatric Obesity;2024-03-04